Twist Bioscience (TWST) on Monday reported preliminary unaudited Q1 revenue of about $103.7 million, up 17% from a year earlier.
Analysts polled by FactSet expect $100.3 million.
The company said it will release full Q1 results on Feb. 2 before the US market opens.
Twist Bioscience shares were more than 1% higher in premarket trading.
.